期刊文献+

综合方法对孕早和中期唐氏综合征筛查的研究 被引量:1

Multi-marks screening for Down's syndrome at early and mid pregnancy
原文传递
导出
摘要 目的探讨唐氏综合征在正常孕妇与高危孕妇的发病率。方法对2004年6月至2006年3 月本院收治的588例孕9-22周孕妇,采用比利时T21*SOFT-w软件作血清风险评估,结合彩色多普勒超声(彩超)测量胎儿颈部半透明厚度、股骨长度、胎耳长度及胎儿结构等,综合对唐氏综合征筛查进行评估。对筛查出的高风险患者行羊水或脐带血染色体确诊,并设高危病例与普通病例对照分析。结果高危病例较普通病例的21-三体、胎儿开放型神经管缺陷(ONTD,包括无脑儿、脊椎裂、脑积水等)发病率高,差异有显著意义(P<0.05);高危病例与普通病例18-三体发病率差异无显著意义(P>0.05);孕妇血清结合彩超筛查,可提高21三体、ONTD检出率。结论孕妇血清风险评估结合彩超诊断对孕早、中期唐氏综合征筛查有重要的意义。 Objective To investigate the incidence of Dawn's syndrome in the normative pregnant woman and the high risk pregnant woman. Methods Multi-marks such as the maternal serum markers of Belgium software T21 * SOFT-w, nuchal translucency, femur length, fetal ear length and abnormal structure with color doppler flow imaging (CDFI) was used for screening Dawn's syndrome in 588 pregnant women at about 9- 22 weeks from June 2004 to March 2006. Results Incidence of Down's syndrome and ONTD(anencephaly, rachischisis, hydrocephalus,et al)in the high risk pregnancy group were significantly higher than that in the normative group (P〈0.05) ; incidence of trisomy 18 syndrome Was no significant difference between two groups (P〉0.05). The sensitivity and specificity for screening Down's syndrome and ONTD was increased by the maternal serum markers with CDFI than just by the maternal serum markers or by CDFI. Conclusion Serum marks with CDFI may play an important role in screening for Down's syndrome at early and mid pregnancy.
作者 潘淑媛 苏玛
出处 《中华妇幼临床医学杂志(电子版)》 CAS 2006年第3期149-151,共3页 Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition)
关键词 唐氏综合征 孕早期 孕中期 筛查 血清标记 彩色多普勒超声 Down's syndrome early and mid pregnancy screening serum marks color doppler flow imaging
  • 相关文献

参考文献3

二级参考文献22

  • 1Hsu J J, Hsieh TT, Hsieh FJ. Down' s syndrome screening in an Asian population using alpha-fetoprotein and free β-HCG: a report of the Taiwan Down' s syndrome screening group. Obstet Gynecol,1996,87 (6): 943-947
  • 2Cuckle HS,Wald NJ ,Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down' s syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol, 1987,94(5): 387-402
  • 3Chik L, Spencer K, Johnson MP, et al. Precise gaussian distribution functions of maternal serum α-fetoprotein and free β-subunit of human chorionic gonadotropin for trisomy 21 screening:improved accuracy for patient counseling. Am J Obstet Gynecol, 1997
  • 4O'Brien WF,Knuppel RA, Torres C, et al. Potential prenatal predictions of Down' s syndrome: a statistical analysis. Am J Obstet Gynecol, 1990,163(6 Pt 1) : 1796-1798
  • 5Hsu JJ,Hsieh TT, Soong YK, et al. Comparison of Down's syndrome screening strategies in Asians combining serum free betahCG and alpha-fetoprotein with maternal age. Prenat Diagn, 1997,17(8) :707-716
  • 6Spencer K. Screening for Down' s syndrome: the role of intact hCG and free subunit measurement. Scand J Clin Lab Invest, 1993,53(suppl 216): 79-96
  • 7Hsu J J, Chiu TH, Chen KC, et al. Maternal serum alpha-fetoprotein levels between 13 and 24 weeks' gestation. Chang Gung Med J,1994,17 (12): 309-315
  • 8Jobanputra V, Roy KK, Kucheria K. Prenatal detection of aneuploidies using fluorescence in situ hybridization: a preliminary experience in an Indian set up. J Biosci,2002,27(2): 155-163
  • 9Miny P, Tercanli S, Holzgreve W. Developments in laboratory techniques for prenatal diagnosis. Curr Opin Obstet Gynecol, 2002,14(2) : 161-168
  • 10Speel EJ, Ramaekers FC, Hopman AH. PCR-based detection of nucleic acids in chromosomes, cells, and tissues: technical considerations on PRINS and in situ PCR and comparison with in situ hybridization. Methods Mol Biol, 2003,226 ( 5 ): 405-424

共引文献60

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部